Short Report: Exploring the Effect of Prenatal Fatty Acid Supplementation on Wheeze and Asthma in Black American Children
Kate Keenan,Sarah Walton,Kimberley Mbayiwa,Lara Akande,Anna Cherian,Christina Ciaccio,Ilaria Tare
DOI: https://doi.org/10.2147/jaa.s474009
2024-09-27
Journal of Asthma and Allergy
Abstract:Kate Keenan, 1 Sarah Walton, 1 Kimberley Mbayiwa, 1 Lara Akande, 1 Anna Cherian, 2 Christina Ciaccio, 2 Ilaria Tare 1 1 Department of Psychiatry and Behavioral Neuroscience, The University of Chicago, Chicago, IL, USA; 2 Department of Pediatrics, The University of Chicago, Chicago, IL, USA Correspondence: Kate Keenan, Department of Psychiatry and Behavioral Neuroscience, The University of Chicago, 5841 South Maryland Avenue, MC3077, Chicago, IL, 60637, USA, Tel +1-773-702-4449, Email Background: Black American children are at higher risk for developing asthma than White children. Identifying potential scalable preventive interventions that can reduce the racial disparities in asthma prevalence and associated morbidity and mortality are needed. We leveraged data from an RCT of prenatal supplementation with docosahexaenoic acid (DHA) in Black American women, to explore whether prenatal fatty acid supplementation is associated with offspring wheeze and asthma. Methods: Data were from the Nutrition and Pregnancy Study (NAPS), a double-blind RCT of prenatal DHA supplementation in Black women targeting stress regulation during pregnancy. A subset of mothers (n = 83) completed a standardized questionnaire on offspring wheeze and asthma when children were between 0.5 and 5.5 years of age. DHA levels were measured from venous blood and reported as percent of total fatty acids. Results: Of the 83 mothers providing data on child wheeze and asthma, 57 (68.7%) had been randomized to active DHA and 26 (31.3%) to placebo. Mothers and research staff were blind to group assignment. Comparison at the group assignment level yielded a relative reduction of 32% in the rate of wheeze or asthma among offspring of mothers assigned to active DHA compared to offspring of mothers assigned to placebo (OR = 1.6 [95% CI = 0.50– 5.09], p = 0.426). DHA levels measured at 25– 29 and 33– 37 weeks of gestation differed as a function of offspring wheeze or asthma (t = 2.21, p = 0.015 and t = 2.54, p = 0.007, respectively). Conclusion: These preliminary data suggest that increasing prenatal levels of DHA could be considered as a potential prevention for asthma in Black American children. Keywords: Asthma, omega-3 fatty acids, pregnancy, Black American Asthma is a chronic inflammatory lung disease that currently affects an estimated 8.4% of children in the United States, resulting in over 600,000 emergency department (ED) visits and over 75,000 hospitalizations each year. 1 For decades, the burden of asthma in the US has fallen disproportionately on Black children living in low-income communities, for whom the prevalence, rates of hospitalization, morbidity, and mortality far exceeds those of their White peers. 2,3 Black children have 2–3 times higher rates of hospitalization and ED visits compared with White children, and a nearly 5-fold increase in asthma-related mortality. 4,5 Data from studies in Chicago show that asthma prevalence in predominantly Black neighborhoods is nearly double the prevalence in predominantly White neighborhoods. 6 Several observational and randomized controlled trials (RCT), most of which have been comprised largely of White participants, have shown that prenatal fatty acid supplementation is associated with a reduction in offspring wheeze and asthma. Results from one of the largest RCTs of prenatal fatty acid, which was conducted in White women in Denmark, showed a 30% reduction in the risk for asthma in the supplemented group compared to the placebo group. 7 To date, research on fatty acids and asthma in youth living in the US also has largely been focused on White children. An exception is the Conditions Affecting Neurocognitive Development and Learning in Early Childhood (CANDLE) study in which two-thirds of the participants identified as Black. 8 In the CANDLE study, omega-3 fatty acid levels measured from maternal venous blood collected during the second trimester and quantified as quartiles were associated with a decreased risk for child asthma. Potential effects of maternal race on the association between prenatal omega-3 fatty acids and child asthma were controlled for statistically. 8 Additional research is needed to provide further evidence or lack thereof of the protective effects of prenatal fatty acids on asthma in Black American youth. Testing the association within racial groups and specification of blood levels at which protection may be increased is warranted to begin laying a foundation for implementation science. In the present study, we compare maternal omega-3 fatty acid levels for children with and without wheeze or asthma by using data from a comple -Abstract Truncated-
immunology,allergy,respiratory system